DRTS
insider transactionsAlpha Tau Medical Ltd. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-32.5K
0 buy · 32.5K sell
Net value · 30d
-$352.1K
$0 in · $352.1K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
2
0 buy · 32.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Raphi Levy KEY
Chief Financial Officer
$161.4K
15.0K sh · $10.76
Own -9%
-
Sell·S
Raphi Levy KEY
Chief Financial Officer
$190.8K
17.5K sh · $10.90
Own -10%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Raphi Levy KEY | Sell S | 15.0K | $161.4K |
| Jun 3, 2026 | Raphi Levy KEY | Sell S | 17.5K | $190.8K |
About DRTS insider trading
This page tracks insider transactions for Alpha Tau Medical Ltd. (DRTS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.